Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research & Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang 421001, China; Hunan Province Key Laboratory for Antibody-Based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, China.
Hunan Province Key Laboratory for Antibody-Based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, China.
Int Immunopharmacol. 2020 Sep;86:106700. doi: 10.1016/j.intimp.2020.106700. Epub 2020 Jun 23.
Cancer is a critical issue globally with high incidence and mortality, imposing great burden on the society. Although great progress has been made in immunotherapy based on immune checkpoint, only a subset of patients responds to this treatment, suggesting that cancer immune evasion is still a major barrier in current immunotherapy. There are a series of factors contributing to immune evasion despite in an immunocompetent environment. Given that these factors are involved in different steps of the cancer immune cycle. In this review, we discuss the mechanisms of immune escape in each step of the cancer immune cycle and then present therapeutic strategies for overcoming immune escape, with the potential to better understand the determinants of immune escape and make anti-tumor immunity more effective.
癌症是一个全球性的重大问题,其发病率和死亡率都很高,给社会带来了巨大的负担。尽管基于免疫检查点的免疫疗法已经取得了很大的进展,但只有一部分患者对这种治疗有反应,这表明癌症的免疫逃逸仍然是当前免疫疗法的一个主要障碍。尽管在免疫功能正常的环境中,仍有一系列因素导致免疫逃逸。鉴于这些因素涉及癌症免疫周期的不同步骤,在本综述中,我们讨论了癌症免疫周期每个步骤中的免疫逃逸机制,然后提出了克服免疫逃逸的治疗策略,这有可能使我们更好地了解免疫逃逸的决定因素,并使抗肿瘤免疫更有效。